IMBRIANO, Carol
 Distribuzione geografica
Continente #
NA - Nord America 13.906
AS - Asia 6.439
EU - Europa 5.979
SA - Sud America 954
Continente sconosciuto - Info sul continente non disponibili 200
AF - Africa 147
OC - Oceania 81
Totale 27.706
Nazione #
US - Stati Uniti d'America 13.574
IT - Italia 2.088
SG - Singapore 2.024
CN - Cina 1.622
GB - Regno Unito 1.283
HK - Hong Kong 773
BR - Brasile 720
VN - Vietnam 699
SE - Svezia 654
DE - Germania 399
BD - Bangladesh 335
FR - Francia 291
FI - Finlandia 239
RU - Federazione Russa 236
KR - Corea 183
UA - Ucraina 176
IN - India 169
CA - Canada 150
ID - Indonesia 125
TR - Turchia 114
JP - Giappone 96
MX - Messico 93
AR - Argentina 85
NL - Olanda 85
AU - Australia 80
BG - Bulgaria 73
ES - Italia 71
CZ - Repubblica Ceca 64
BE - Belgio 51
ZA - Sudafrica 50
PL - Polonia 49
IE - Irlanda 44
LT - Lituania 43
IQ - Iraq 41
EC - Ecuador 38
CO - Colombia 33
AE - Emirati Arabi Uniti 28
AT - Austria 27
MY - Malesia 25
PK - Pakistan 25
UZ - Uzbekistan 25
EG - Egitto 22
MA - Marocco 22
CH - Svizzera 20
SA - Arabia Saudita 20
CL - Cile 19
CR - Costa Rica 19
PH - Filippine 19
VE - Venezuela 17
PY - Paraguay 15
TW - Taiwan 15
UY - Uruguay 14
TH - Thailandia 12
TN - Tunisia 12
DZ - Algeria 11
JM - Giamaica 11
IL - Israele 10
IR - Iran 10
NP - Nepal 10
PT - Portogallo 10
ET - Etiopia 9
JO - Giordania 9
KE - Kenya 9
LB - Libano 9
NI - Nicaragua 9
PE - Perù 9
AL - Albania 8
HN - Honduras 8
RS - Serbia 8
GR - Grecia 7
RO - Romania 7
EE - Estonia 6
GT - Guatemala 6
SI - Slovenia 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
BB - Barbados 5
BY - Bielorussia 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
PA - Panama 5
PR - Porto Rico 5
SN - Senegal 5
GE - Georgia 4
HR - Croazia 4
HU - Ungheria 4
KZ - Kazakistan 4
LV - Lettonia 4
AM - Armenia 3
BH - Bahrain 3
BO - Bolivia 3
BZ - Belize 3
CI - Costa d'Avorio 3
CW - ???statistics.table.value.countryCode.CW??? 3
EU - Europa 3
KG - Kirghizistan 3
KW - Kuwait 3
LK - Sri Lanka 3
SK - Slovacchia (Repubblica Slovacca) 3
BA - Bosnia-Erzegovina 2
Totale 27.479
Città #
Ashburn 1.702
Singapore 1.236
Santa Clara 1.148
Fairfield 1.059
Southend 758
San Jose 750
Hong Kong 747
Woodbridge 658
Chandler 594
Council Bluffs 534
Hefei 512
Houston 451
Seattle 395
Ann Arbor 384
Modena 383
Cambridge 356
Wilmington 345
Nyköping 303
Jacksonville 296
Beijing 283
Los Angeles 262
Dearborn 256
London 229
New York 229
Ho Chi Minh City 215
Milan 205
Bologna 176
Hanoi 172
The Dalles 167
Seoul 164
Chicago 145
Helsinki 138
San Diego 104
Jakarta 95
Reggio Emilia 91
Munich 81
Austin 80
Lauterbourg 79
Shanghai 75
Moscow 74
Tokyo 73
Buffalo 72
Dallas 71
São Paulo 71
Princeton 70
Sofia 67
Phoenix 64
Columbus 59
Eugene 59
Parma 59
Izmir 53
Bremen 51
Orem 50
Rome 50
Round Rock 50
Brno 45
Dong Ket 45
Salt Lake City 45
Fremont 43
Brussels 41
Mexico City 41
Warsaw 41
Boardman 39
Denver 39
Atlanta 38
Turku 38
Da Nang 37
Montreal 37
Brooklyn 36
Frankfurt am Main 36
Dublin 34
Naples 32
Poplar 32
Toronto 32
Durham 29
Johannesburg 29
Redwood City 29
Chennai 28
Formigine 27
Mumbai 27
Stockholm 27
San Francisco 26
Kent 25
Paris 25
Tampa 25
Turin 25
Des Moines 24
Falls Church 24
Rio de Janeiro 24
Tashkent 24
Amsterdam 23
Elk Grove Village 23
Haiphong 23
Baghdad 22
Norwalk 22
Nuremberg 22
Washington 22
Brasília 21
Belo Horizonte 20
Florence 20
Totale 18.217
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 601
Dynamic Phosphorylation of the Myocyte Enhancer Factor 2Cα1 Splice Variant Promotes Skeletal Muscle Regeneration and Hypertrophy 468
Dynamic recruitment of NF-Y and histone acetyltransferases on cell-cycle promoters 457
An autoregulatory loop controls the expression of the transcription factor NF-Y 445
Potent Anti-Cancer Properties of Phthalimide-Based Curcumin Derivatives on Prostate Tumor Cells 434
NF-YA splice variants have different roles on muscle differentiation 425
NF-Y splice variants differentially affect skeletal myogenesis 424
Newly synthesized curcumin derivatives: crosstalk between chemico-physical properties and biological activity. 420
Curcumin derivatives and Aβ-fibrillar aggregates: An interactions’ study for diagnostic/therapeutic purposes in neurodegenerative diseases 419
Phosphorylation and alternative splicing of MEF2C, a dual switch function in muscle regeneration 413
Direct non transcriptional role of NF-Y in DNA replication 399
A balance between NF-Y and p53 governs the pro- and anti-apoptotic transcriptional response 397
Curcumin derivatives: molecular basis of their anti-cancer activity. 397
Concurrent inhibition of enzymatic activity and NF-Y-mediated transcription of Topoisomerase-IIα by bis-DemethoxyCurcumin in cancer cells 395
Direct p53 transcriptional repression: In vivo analysis of CCAAT-containing G2/M promoters 389
Transcriptionally regulated and nontoxic delivery of the hyperactive Sleeping Beauty Transposase 389
bis-Dehydroxy-Curcumin Triggers Mitochondrial-Associated Cell Death in Human Colon Cancer Cells through ER-Stress Induced Autophagy. 382
NF-Y recruitment of TFIID, multiple interactions with histone fold TAF(II)s 379
Transcriptionally regulated and non-toxic delivery of the hyperactive Sleeping Beauty Transposase 379
NF-Y activates genes of metabolic pathways altered in cancer cells 369
The NF-Y/p53 liaison: Well beyond repression. 365
Transcriptional activation of the cyclin A gene by the architectural transcription factor HMGA2 363
Alternative splicing of transcription factors genes in muscle physiology and pathology 360
Cloning and characterization of the histone-fold proteins YBL1 and YCL1 359
Dissection of the NF-Y transcriptional activation potential 359
New curcumin-derived ligands and their affinity towards Ga3+, Fe3+and Cu2+: Spectroscopic studies on complex formation and stability in solution 356
HSP-CBF is an NF-Y-dependent coactivator of the heat shock promoters CCAAT boxes 355
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 355
NF-Y co-associates with FOS at promoters, enhancers, repetitive elements, and inactive chromatin regions, and is stereo-positioned with growth-controlling transcription factors. 353
Structure-Based Design of Potent Aromatase Inhibitors by High-Throughput Docking 352
NF-Y loss triggers p53 stabilization and apoptosis in HPV18-positive cells by affecting E6 transcription 344
Ternary complex formation between MADS-box transcription factors and the histone fold protein NF-YB 338
An acetylation-mono-ubiquitination switch on lysine 120 of H2B 336
Alternative splicing of the transcription factor NF-Y promotes cell migration and invasion in colon cancer 334
Gain-of-function p53 mutants have widespread genomic locations partially overlapping with p63 333
The interplay between NF-Y, AR and lipid metabolism regulates tumor aggressiveness in prostate cancer. 332
The 1,10-phenanthroline ligand enhances the antiproliferative activity of dna-intercalating thiourea-pd(Ii) and-pt(ii) complexes against cisplatin-sensitive and-resistant human ovarian cancer cell lines 331
A specific role for the splice variants of the transcription factor NF-Y in modulating the transcriptional activity of the myogenic program 330
Dysregulation of NF–Y splicing drives metabolic rewiring and aggressiveness in colon cancer 329
DNA damage promotes histone deacetylase 4 nuclear localization and repression of G2/M promoters via p53 C-terminal lysines 328
Switch of NF-YA splice variants in prostate cancer development and progression 328
Scouting Sigma Receptor Ligands As New Tools For The Treatment Of Neurodegenerative Diseases And Cancer 325
BS148 Reduces the Aggressiveness of Metastatic Melanoma via Sigma-2 Receptor Targeting 319
Specific inhibition of NF-Y subunits triggers different cell proliferation defects. 319
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 302
Probing solute–solvent hydrogen bonding with fluorescent water-soluble curcuminoids 299
NF-Y LOSS REACTIVATES p53 AND TRIGGERS p53-DEPENDENT APOPTOSIS IN HPV-POSITIVE HUMAN CERVICAL CARCINOMA CELLS 299
A non transcriptional role for NF-Y in DNA replication 298
Alterations in NF-Y splicing enable the metabolic plasticity of colon cancer cells and foster dynamic interactions within the tumor niche 297
Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads 294
Role of the CCAAT-transcription factor NF-Y and its splice variants in myogenic differentiation and muscle regeneration 286
NF-YC complexity is generated by dual promoters and alternative splicing 284
Polymer-lipid hybrid nanomedicines to deliver siRNA in and against glioblastoma cells 283
Development of new metal-chelating multi target drus derived from Curcumin 283
Dynamic recruitment of transcription factors and epigenetic changes on the ER stress response gene promoters 281
The transcription factor NF-Y participates to stem cell fate decision and regeneration in adult skeletal muscle 278
Direct non transcriptional role of the CCAAT-factor NF-Y in DNA replication 274
Role of the transcriprion factor NF-Y in cell cycle regulation 273
Transcription Factors in Cancer: When Alternative Splicing Determines Opposite Cell Fates 271
The NF-YA splicing signature controls aggressiveness of colon cancer by regulating different modes of cell migration and cell metabolism. 269
The NF-YA Splicing Signature Controls Aggressiveness of Colon Cancer by Regulating Cell Metabolism and Different Types of Cell Migration 268
Development of new therapeutic Metal(III)-chelating agents derived from Curcumin 268
Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer 266
Monitoring DNA Hybridization with Organic Electrochemical Transistors Functionalized with Polydopamine 263
The transcription factor NF-Y is required for satellite stem cell proliferation and skeletal muscle tissue repair 261
Bridging pyrimidine hemicurcumin and Cisplatin: Synthesis, coordination chemistry, and in vitro activity assessment of a novel Pt(II) complex 256
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 249
The NF–Y splicing signature controls hybrid EMT and ECM-related pathways to promote aggressiveness of colon cancer 248
Development of Stable Amino-Pyrimidine–Curcumin Analogs: Synthesis, Equilibria in Solution, and Potential Anti-Proliferative Activity 245
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group 238
DNA damage promotes HDAC4 nuclear localization and G2/M promoters repression via p53 C-terminal lysisnes 236
Development of new metal-based phyto-radiopharmaceuticals: diagnostic agents derived from Cur(e)cumin 235
Understanding the molecular mechanisms of Curcumin derivatives chemotherapic activity 231
Expression of the CCAAT-binding factor NF-Y in Caenorhabditis elegans 228
Investigation of transcription factor–DNA binding with electrolyte-gated organic transistors 226
Cell cycle regulation of NF-YC nuclear localization 215
In situ immunofluorescent staining of autophagy in muscle stem cells 212
Histone deacetylase functions and therapeutic implications for adult skeletal muscle metabolism 198
Deciphering the transcriptional network of NF-Y in prostate cancer development and progression 196
Epitranscriptomics as a New Layer of Regulation of Gene Expression in Skeletal Muscle: Known Functions and Future Perspectives 193
Searching for Novel HDAC6/Hsp90 Dual Inhibitors with Anti-Prostate Cancer Activity: In Silico Screening and In Vitro Evaluation 180
Histone Marks-Dependent Effect on Alternative Splicing: New Perspectives for Targeted Splicing Modulation in Cancer? 166
The transcription factor NF-Y participates in prostate cancer progression and response to androgen-deprivation therapy 162
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356 158
Cross-talk between NF-Y transcription factor and m6A epitanscriptomic regulators in colon cancer: molecular characterization and clinical relevance. 152
The transcription factor NF-Y is required for satellite stem cell myogenic progression and skeletal muscle tissue repair 150
Nuclear Estrogen Receptors in Prostate Cancer: From Genes to Function 141
The NF–Y splicing signature controls hybrid EMT and ECM-related pathways to promote aggressiveness of colon cancer 136
Targeting monocarboxylate transporter 1 with a copper-chelating coumarin-based bioconjugate: Synthesis and characterization 127
Correction: Investigation of transcription factor-DNA binding with electrolyte-gated organic transistors (J. Mater. Chem. C (2024) 12 (7596–7604) DOI: 10.1039/D4TC00260A) 120
Metabolic reprogramming controlled by NF-YA alternative splicing creates therapeutic opportunities in colorectal cancer 115
The role(s) of NF-Y in development and differentiation 114
MXene‐Based Conductive Micropatterned Composites Promote Myogenic Differentiation of Muscle Cells 49
Structure-Based Discovery of Hsp90/HDAC6 Dual Inhibitors Targeting Aggressive Prostate Cancer 45
null 4
Totale 27.706
Categoria #
all - tutte 97.384
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.384


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.272 0 0 0 113 75 111 101 72 202 135 297 166
2022/20231.960 199 260 125 173 202 246 56 182 204 52 153 108
2023/20241.647 60 75 101 151 295 133 244 135 28 65 135 225
2024/20254.889 146 54 203 323 880 759 434 297 469 271 500 553
2025/20268.823 610 385 684 1.068 1.365 589 1.006 391 855 860 537 473
2026/20272.353 289 578 772 714 0 0 0 0 0 0 0 0
Totale 27.706